Statistics for Profound Medical Corp (id:13577 PRN)
Valuation metrics
Market cap
312.30M
Enterprise value
337.69M
Trailing P/E (ttm)
-7.48
Forward P/E
-9.04
PEG ratio
-9.04
Price/Sales (ttm)
34.76
Price/Book (mrq)
8.25
Enterprise Value/Revenue
26.19
Enterprise Value/EBITDA
-7.25
Overview
Shares outstanding
30.03M
Float
22.31M
Shares short
92.65K
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
10.93K
Average volume (90 days)
Price summary
52-Week low
9.55
52-Week high
15.75
52-Week change
-9.62%
Beta
3.00
50-Day moving average
10.80
200-Day moving average
11.37
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
October 16, 2019
Ex-dividend date
Last split factor
2:1
Last split date
October 16, 2019
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
60.87%
Operating margin
-317.37%
Operational effectiveness
Return on assets
-44.62%
Return on equity
-90.17%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
4.38M
EBITDA
-46,591,648.00
Net income to common (ttm)
-45,058,641.00
Diluted EPS (ttm)
-1.92
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
38.93M
Total cash per share (mrq)
1.10
Total debt (mrq)
8.94M
Total Debt/Equity (mrq)
20.05
Current ratio (mrq)
612.30%
Book value per share (mrq)
1.26
Cash flow
Cash flow statement
-35,638,111.00
Levered free cash flow (LFCF)
-21,222,747.00